Page last updated: 2024-08-23

dianhydrogalactitol and Ovarian Neoplasms

dianhydrogalactitol has been researched along with Ovarian Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grönroos, M; Kangas, L; Mäenpää, J; Paul, R; Vanharanta, R	1
Blessing, JA; Blom, J; Ehrlich, CE; Mangan, C; Stehman, FB	1

Other Studies

2 other study(ies) available for dianhydrogalactitol and Ovarian Neoplasms

Article	Year
Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro. British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:5 Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1984
Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study. Gynecologic oncology, 1983, Volume: 15, Issue:3 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms	1983

Article

Year

Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.

British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:5

Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen

1984

Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.

Gynecologic oncology, 1983, Volume: 15, Issue:3

Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dianhydrogalactitol; Drug Administration Schedule; Drug Evaluation; Female; Humans; Ovarian Neoplasms; Prognosis; Sugar Alcohols; Uterine Cervical Neoplasms

1983